Joy Y. Feng
Infectious Diseases · 2016–2020
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 42 citations into it
Whom Joy Y. Feng trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- A. Ward (in Infectious Diseases)
Papers from Joy Y. Feng's perspective
Ordered by how strongly the researchers Joy Y. Feng trusts endorse each paper. Same corpus, a different order for every researcher.
- Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys (Nature)
- Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. (New England Journal of Medicine)
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics (New England Journal of Medicine)
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (Nature)
- Coronaviruses: An Overview of Their Replication and Pathogenesis (Methods in molecular biology)
- Approved Antiviral Drugs over the Past 50 Years (Clinical Microbiology Reviews)
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Cell Research)
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture (Antimicrobial Agents and Chemotherapy)
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset (Journal of Infectious Diseases)
- A novel coronavirus associated with severe acute respiratory syndrome. (New England Journal of Medicine)
Their papers
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency (2020) — 827 citations
- The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus (2020) — 737 citations
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (2020) — 1,642 citations
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (2018) — 1,318 citations
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (2017) — 1,505 citations
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses (2017) — 623 citations
- Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys (2016) — 1,409 citations